FUREN Group Pharmaceutical Co.,Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 462.47 million compared to CNY 349.32 million a year ago. Revenue was CNY 462.47 million compared to CNY 349.32 million a year ago.

Net loss was CNY 122.9 million compared to CNY 177.27 million a year ago. Basic loss per share from continuing operations was CNY 0.2 compared to CNY 0.28 a year ago. Diluted loss per share from continuing operations was CNY 0.2 compared to CNY 0.28 a year ago.